Mishonga provides integrated cannabis advisory covering the full value chain — GACP cultivation sites, SAHPRA licensing, GMP extraction and manufacturing, product dossier development, INCB compliance, and export authorisation across six jurisdictions.
01
GACP site design & development
End-to-end GACP site development — site selection, facility design, SOP development, staff training, and SAHPRA inspection readiness. Prefeasibility through full build-out.
GACPSite designSOPsInspection prepSAHPRA
02
SAHPRA Section 22A licensing
Full Section 22A licence preparation and submission for cultivation, processing, manufacturing, research, and export — across Tier 1 (hemp), Tier 2 (broad-spectrum), and Tier 3 (pharmaceutical THC).
S22ATier 1Tier 2Tier 3Schedule 7
03
Product dossier development
Pharmaceutical dossier preparation for cannabis-derived products — CBD isolate, THC distillate, dronabinol API, standardised extracts — for SAHPRA, EMA, MHRA, and TGA registration.
DossierCTDAPICBDTHCRegistration
04
INCB & international compliance
Single Convention compliance, INCB import/export authorisation, DEA documentation, and receiving-country import permit coordination for international cannabis shipments.
INCBSingle ConventionExport permitsDEA
05
Government legislation advisory
Advisory to African Union governments on cannabinoid legislation framework design, regulatory authority structure, licensing regime, and international treaty alignment.
GovernmentLegislationPolicyAUFramework
06
GMP manufacturing licensing
GMP cannabis manufacturing site setup and SAHPRA inspection preparation — facility design, equipment qualification, batch record systems, and QP services for Tier 2 and 3 operations.
GMPManufacturingQPInspectionCannabis